Reaction
Inflammatory Pain reporting signals
As of the last recalculation, Inflammatory Pain appears in 669 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is ATROPINE (PRR 57.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Atropine | 15 | 57.6 | 57.7 |
| Atropine Sulfate | 15 | 44.2 | 44.2 |
| Indomethacin | 15 | 36.0 | 36.0 |
| Sulfasalazine | 67 | 29.5 | 29.5 |
| Secukinumab | 93 | 20.7 | 20.7 |
| Testosterone | 15 | 20.4 | 20.4 |
| Diclofenac Potassium | 6 | 17.4 | 17.4 |
| Bimekizumab | 9 | 13.3 | 13.3 |
| Botulinum Toxin Type A | 5 | 12.6 | 12.6 |
| Dronedarone | 4 | 12.3 | 12.3 |
| Golimumab | 29 | 11.0 | 11.0 |
| Ixekizumab | 9 | 7.7 | 7.7 |
| Guselkumab | 8 | 7.0 | 7.0 |
| Sarilumab | 5 | 5.9 | 5.9 |